The research team stated, "Freeze-drying with mannitol is a practical micronization strategy for enhancing the pulmonary delivery efficiency of peptide drugs" adding, "We were the first to confirm the potential of a dry powder inhaler as a next-generation semaglutide delivery platform that can address the limitations of injectable and oral dosage forms" The study, co-authored by Hanmi Pharm
Emerging evidence suggests they may: Reduce inflammation Improve tissue quality Support metabolic health Decrease pain and discomfort But they are not a cureand they work best as part of a comprehensive, individualized plan
Tirzepatide's clinical evidence: The SURMOUNT-1 trial, published in the New England Journal of Medicine (2022), enrolled 2,539 adults with obesity who had at least one weight-related comorbidity excluding diabetes - a population chosen to test tirzepatide's weight management efficacy in a cleanly obesity-focused cohort rather than a diabetes-management context
Market Overview and Size Global Market Growth The obesity drugs market was valued at $20.20 billion in 2024 and is projected to reach $86.71 billion by 2030 , growing at a robust 27.5% CAGR
Many of our customers come from Johns Creek, Alpharetta, Roswell, Cumming, Duluth, Peachtree Corners, Sugar Hill, Berkeley Lake, Sandy Springs (coming soon!), and other cities
Sampson, S., Mansour, M., Maayan, N., Soares-Weiser, K